NASDAQ: INCY - Incyte

Yield per half year: +7.08%
Dividend yield: 0.00%
Sector: Healthcare

Incyte

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
23.76 48.77 -51.28% 36 -33.99%
P/S 3.84 33.77 -88.62%
P/BV 2.74 4.83 -43.33%
P/FCF 31.96 61 -47.61%
Ev/Ebitda 12.19 -22.17 -154.97%
Ev/S 2.98 22.57 -86.78%
Ev/FCF 24.55 68.76 -64.29%
E/P 0.0416 0.0178 134.05%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
24.48 4.97 392.37% 15.36 +59.33%
ROE 11.51 9.61 19.8%
ROA 8.81 0.3443 2459.52%
ROIC 27.97 7.63 266.37%
ROS 16.17 -25.17 -164.24%
ROCE 15.84 15.45 2.53%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.0423 -3.68 -101.15% 0.0514 -17.6%
Nеt Debt/Ebitda -3.51 -3.44 2.1%
Debt/Ratio 0.0056 0.1986 -97.16%
Debt/Equity 0.0518 1.66 -96.88%
Debt/Net Income 0.0641 10.32 -99.38%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.541 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2256 -100%
Average dividend growth 0 0.9598 -100%
Average percentage for 5 years 0 0.4928 -100%
Average percentage for payments 4.88 43.56 -88.81%
Difference from average difference in sector -0.541

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
8/10
71.09 -57.64 -223.33%
Growth impulse Ebitda in 5 years 94.01 -90.94 -203.38%
Growth impulse Net Income in 5 years 33.72 -97.8 -134.48%
Growth impulse FCF in 5 years -29.02 -108.72 -73.31%
Growth impulse EPS in 5 years 29.03 -142.05 -120.44%
IP Score
5.45/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription